InvestorsHub Logo
icon url

Jimmy Joe

04/07/06 11:40 PM

#32599 RE: Paulness #32595

Paul with all due respect you are out there on that one.

"you probably will see a 30 dollar stock at that point" as an indicator of when to buy in.
Nope nope nope nope nope.

Like I have posted previously there may come a point in time where CYGX meets requirements to get listing on NASDAQ. Once listed the institutional investors typically wait until a stock can hold $5 at close for a time period to meet their
minimal requirements. They will also do their research on Cytogenix well in advance waiting for that time to come.
THE TIME TO BUY will be before they start buying because once they start this thing is going nothing but up up up.
The time to buy this stock is now. Speculative? Yes. A slam dunk? Not yet. Very promising though in my most humblest of opinions. At $30/share it will be late to the party with only
leftovers available to those who show. If anything an investor would like to get in before the institutionals start to scoop up their shares.

Now this all depends on what transpires in the meantime Paul.
If something happens for Aldevron or GE that ties in with
CYGX this company could be applying for the Nasdaq or other
sooner than later. Remember both Aldevron and GE Healthcare have nice sized biodefense contracts. Both have projects in the works for a while now. synDNA is only one facet of Cytogenix. Remember that.

So as I tell my clients keep your eyes peeled and your powder dry. Only shoot when you see the whites of their eyes.

Jimmy Joe Meeker Ltd.
icon url

david02835

04/08/06 9:36 AM

#32607 RE: Paulness #32595

Paulness, thank you for your reply. Being patient here is difficult when you feel that you are into a big winner. I had a daydream that everybody (and domestic animal) in the world would be getting a flu shot this year and our "stuff" wouldn't be ready for market until next year. LOL Thanks again.